Search

everythinglearnresearchcommunity

for

Search:↓

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

CXCR2 in skin cells promotes tumor growth.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

Androgen receptors help prostate cancer cells grow and resist drugs.

Skin RAGE levels are linked to inflammation and cell death.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Targeting Keratin 17 may help overcome cancer therapy resistance.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

WYE-130600 may cause skin thickening and irritation.

EK significantly improved wound healing and reduced infection in burn wounds.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Blocking mTORC1 reduces skin tumor growth in mice.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Erk signaling helps zebrafish fins regrow to the right size by using memory of the original size.